The Saul R. Korey Department of Neurology


NIH-funded research:

NINDS Stroke Trials Network - Regional Coordinating Stroke Center. Mark Mehler MD, Principal Investigator, in partnership with Mt. Sinai and NYU Langone Schools of Medicine: 

Automated Directly Observed Therapy in a Stroke Population. Daniel Labovitz MD, Principal Investigator in partnership with AI Cure Technologies: 

Industry-funded research:

Biogen: natalizumab for acute stroke phase 2 clinical trial

Asubio: SUN13837 for acute ischemic stroke phase 2 clinical trial

Selection of recent and on-going intramural research:

TIA-Infarct Ratio Study: abstracts presented at the American Academy of Neurology and International Stroke Conference 2012, European Stroke Conference, London, UK 2013.

Management of atrial fibrillation prior to stroke: abstract presented at the European Stroke Conference, London, UK 2013.

Capsular warning syndrome case report with a novel conceptual framework: The capsular warning syndrome reconsidered. Cerebrovascular Diseases 2013.

Teaching video neuroimages: callosal apraxia: a straightforward model of ideomotor apraxia. Neurology, 2013.

Stern Stroke Center Menu





Click here to log in